Basal Cell Carcinoma Treatment Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017 - 2025
Report Highlights
Basal Cell Carcinoma Treatment Market: Overview
This report on the global basal cell carcinoma treatment market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases.
A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also provide insights into the key trends of the basal cell carcinoma treatment market such as augmentation in clinical trials, increase in private insurance and favorable reimbursement scenario. The key market indicators influencing global basal cell carcinoma treatment market taken into consideration including cost constraints and regulatory landscape.
Basal Cell Carcinoma Treatment Market: Scope of the Study
The report provides market size in terms of US$ Mn for each segment for the period from 2015 to 2025, considering the macro and micro environmental factors. Growth rates for each segment within the global basal cell carcinoma treatment market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements. It also includes value chain analysis of the global basal cell carcinoma treatment industry. A pipeline analysis highlighting major pipeline drugs is also included in the report.
Market revenue in terms of US$ Mn for the period between 2015 and 2025 along with the compound annual growth rate (CAGR %) from 2017 to 2025 are provided for all the segments, considering 2016 as the base year. The year on year growth of global basal cell carcinoma treatment market for each segment is also reflected. Additionally, market related factors such as technological advancements, changing environmental factors, and growing disease awareness initiatives and greater affordability for patients in various geographies and historical year-on-year growth have been taken into consideration while estimating the market size.
Basal Cell Carcinoma Treatment Market: Segmentation
Based on treatment type, the global basal cell carcinoma treatment market has been segmented into surgical (surgical excision, electrodessication & cutterage (ED&C), Moh's surgery, and cryosurgery), drugs (topical treatment, advanced medication, and other) and others. Based on end-user, the market has been segmented into hospitals, specialty clinics, and others. Hospitals segment is expected to remain dominant during the forecast period.
Geographically, the global basal cell carcinoma treatment market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In addition, the regions have been further segmented into major countries in each of the regions. These include the U.S., Canada, the U.K., Germany, France, Italy, Spain, China, Australia, Japan, Brazil, GCC, South Africa and Mexico.
Basal Cell Carcinoma Treatment Market: Competitive Landscape
The report includes market attractiveness analysis of the major segments that provides a thorough analysis of the overall competitive scenario in the global basal cell carcinoma treatment market. It profiles major players in the basal cell carcinoma treatment market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments.
A thorough market share analysis of major companies operating in the basal cell carcinoma treatment market is provided in the report. Key companies profiled in the report include Sun Pharmaceuticals Ltd., Valeant Pharmaceuticals International, Inc., Mylan N.V., F. Hoffmann-La Roche Ltd., and Merck & Co., Inc.
The global basal cell carcinoma treatment market has been segmented as follows:
By Treatment Type
Surgical
Surgical Excision
Electrodessication & Cutterage (ED&C)
Moh's Surgery
Cryosurgery
Drugs
Topical Treatment
Advanced Medication
Other
Others
Radiation Therapy
Photodynamic Therapy (PDT)
Laser Therapy
By End User
Hospitals
Specialty Clinics
Others
By Geography
North America
U.S.
Canada
Europe
U.K.
Germany
France
Spain
Italy
Rest of Europe
Asia Pacific
Australia & New Zealand
Japan
China
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
South Africa
GCC
Rest of Middle East & Africa
- Table 1 : Global Basal Cell Carcinoma Treatment Market Size (US$ Mn) Forecast, by Treatment, 2017–2025
- Table 2 : Global Basal Cell Carcinoma Treatment Market Size (US$ Mn) Forecast, by Surgical Treatment, 2017–2025
- Table 3 : Global Basal Cell Carcinoma Treatment Market Size (US$ Mn) Forecast, by Drugs Treatment, 2017–2025
- Table 4 : Global Basal Cell Carcinoma Treatment Market Size (US$ Mn) Forecast, by Other Treatment, 2017–2025
- Table 5 : Global Basal Cell Carcinoma Treatment Market Size (US$ Mn) Forecast, by End-user, 2017–2025
- Table 6 : Global Basal Cell Carcinoma Treatment Market Size (US$ Mn) Forecast, by Region, 2017–2025
- Table 7 : North America Basal Cell Carcinoma Treatment Market Size (US$ Mn) Forecast, by Treatment, 2017–2025
- Table 8 : North America Basal Cell Carcinoma Treatment Market Size (US$ Mn) Forecast, by Surgical Treatment
- Table 9 : North America Basal Cell Carcinoma Treatment Market Size (US$ Mn) Forecast, by Drugs Treatment
- Table 10 : North America Basal Cell Carcinoma Treatment Market Size (US$ Mn) Forecast, by Other Treatment
- Table 11 : Global Basal Cell Carcinoma Treatment Market Size (US$ Mn) Forecast, by End-user, 2017–2025
- Table 12 : North America Basal Cell Carcinoma Treatment Market Size (US$ Mn) Forecast, by Country, 2017–2025
- Table 13 : Europe Basal Cell Carcinoma Treatment Market Size (US$ Mn) Forecast, by Treatment, 2017–2025
- Table 14 : Europe Basal Cell Carcinoma Treatment Market Size (US$ Mn) Forecast, by Surgical Treatment, 2017–2025
- Table 15 : Europe Basal Cell Carcinoma Treatment Market Size (US$ Mn) Forecast, by Drugs Treatment, 2017–2025
- Table 16 : Europe Basal Cell Carcinoma Treatment Market Size (US$ Mn) Forecast, by Other Treatment, 2017–2025
- Table 17 : Europe Basal Cell Carcinoma Treatment Market Size (US$ Mn) Forecast, by End-user, 2017–2025
- Table 18 : Europe Basal Cell Carcinoma Treatment Market Size (US$ Mn) Forecast, by Country, 2017–2025
- Table 19 : Asia Pacific Basal Cell Carcinoma Treatment Market Size (US$ Mn) Forecast, by Treatment, 2017–2025
- Table 20 : Asia Pacific Basal Cell Carcinoma Treatment Market Size (US$ Mn) Forecast, by Surgical Treatment
- Table 21 : Asia Pacific Basal Cell Carcinoma Treatment Market Size (US$ Mn) Forecast, by Drugs Treatment, 2017–2025
- Table 22 : Asia Pacific Basal Cell Carcinoma Treatment Market Size (US$ Mn) Forecast, by Other Treatment, 2017–2025
- Table 23 : Asia Pacific Basal Cell Carcinoma Treatment Market Size (US$ Mn) Forecast, by End-user, 2017–2025
- Table 24 : Asia Pacific Basal Cell Carcinoma Treatment Market Size (US$ Mn) Forecast, by Country, 2017–2025
- Table 25 : Latin America Basal Cell Carcinoma Treatment Market Size (US$ Mn) Forecast, by Treatment, 2017–2025
- Table 26 : Latin America Basal Cell Carcinoma Treatment Market Size (US$ Mn) Forecast, by Surgical Treatment
- Table 27 : Latin America Basal Cell Carcinoma Treatment Market Size (US$ Mn) Forecast, by Drugs Treatment
- Table 28 : Latin America Basal Cell Carcinoma Treatment Market Size (US$ Mn) Forecast, by Other Treatment
- Table 29 : Latin America Basal Cell Carcinoma Treatment Market Size (US$ Mn) Forecast, by End-user, 2017–2025
- Table 30 : Latin America Basal Cell Carcinoma Treatment Market Size (US$ Mn) Forecast, by Country, 2015–2025
- Table 31 : Middle East & Africa Basal Cell Carcinoma Treatment Market Size (US$ Mn) Forecast, by Treatment
- Table 32 : Middle East & Africa Basal Cell Carcinoma Treatment Market Size (US$ Mn) Forecast, by Surgical Treatment, 2017–2025
- Table 33 : Middle East & Africa Basal Cell Carcinoma Treatment Market Size (US$ Mn) Forecast, by Drugs Treatment, 2017–2025
- Table 34 : Middle East & Africa Basal Cell Carcinoma Treatment Market Size (US$ Mn) Forecast, by Other Treatment, 2017–2025
- Table 35 : Middle East & Africa Basal Cell Carcinoma Treatment Market Size (US$ Mn) Forecast, by End-user
- Table 36 : Middle East & Africa Basal Cell Carcinoma Treatment Market Size (US$ Mn) Forecast, by Country, 2015–2025
- Figure 1 : Basal Cell Carcinoma Treatment Market Snapshot
- Figure 2 : Global Basal Cell Carcinoma Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2015–2025
- Figure 3 : Market Value Share by Treatment (2016)
- Figure 4 : Market Value Share by End-user (2016)
- Figure 5 : Market Value Share by Region (2016)
- Figure 6 : Global Basal Cell Carcinoma Treatment Market Value Share Analysis, by Treatment, 2016 and 2025
- Figure 7 : Global Basal Cell Carcinoma Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Surgical Treatment, 2015–2025
- Figure 8 : Global Basal Cell Carcinoma Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Drugs Treatment, 2015–2025
- Figure 9 : Global Basal Cell Carcinoma Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2015–2025
- Figure 10 : Global Basal Cell Carcinoma Treatment Market Attractiveness Analysis, by Treatment
- Figure 11 : Global Basal Cell Carcinoma Treatment Market Value Share Analysis, by End-user, 2016 and 2025
- Figure 12 : Global Basal Cell Carcinoma Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2015–2025
- Figure 13 : Global Basal Cell Carcinoma Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Specialty Clinics, 2015–2025
- Figure 14 : Global Basal Cell Carcinoma Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2015–2025
- Figure 15 : Global Basal Cell Carcinoma Treatment Market Attractiveness Analysis, by End-user
- Figure 16 : Global Basal Cell Carcinoma Treatment Market Value Share Analysis, by Region, 2016 and 2025
- Figure 17 : Global Basal Cell Carcinoma Treatment Market Attractiveness Analysis, by Region
- Figure 18 : North America Basal Cell Carcinoma Treatment Market Size (US$ Mn) Forecast, 2017–2025
- Figure 19 : North America Market Attractiveness Analysis, by Country
- Figure 20 : North America Basal Cell Carcinoma Treatment Market Value Share Analysis, by Treatment, 2016 and 2025
- Figure 21 : North America Basal Cell Carcinoma Treatment Market Value Share Analysis, by End-user, 2016 and 2025
- Figure 22 : North America Basal Cell Carcinoma Treatment Market Value Share Analysis, by Country, 2016 and 2025
- Figure 23 : North America Basal Cell Carcinoma Treatment Market Attractiveness Analysis, by Treatment
- Figure 24 : North America Basal Cell Carcinoma Treatment Market Attractiveness Analysis, by End-user
- Figure 25 : Europe Basal Cell Carcinoma Treatment Market Size (US$ Mn) Forecast, 2017–2025
- Figure 26 : Europe Basal Cell Carcinoma Treatment Market Attractiveness Analysis, by Country
- Figure 27 : Europe Basal Cell Carcinoma Treatment Market Value Share Analysis, by Treatment, 2016 and 2025
- Figure 28 : Europe Basal Cell Carcinoma Treatment Market Value Share Analysis, by End-user, 2016 and 2025
- Figure 29 : Europe Basal Cell Carcinoma Treatment Market Value Share Analysis, by Country, 2016 and 2025
- Figure 30 : Europe Basal Cell Carcinoma Treatment Market Attractiveness Analysis, by Treatment
- Figure 31 : Europe Basal Cell Carcinoma Treatment Market Attractiveness Analysis, by End-user
- Figure 32 : Asia Pacific Basal Cell Carcinoma Treatment Market Size (US$ Mn) Forecast, 2015–2025
- Figure 33 : Asia Pacific Basal Cell Carcinoma Treatment Market Attractiveness Analysis, by Country
- Figure 34 : Asia Pacific Basal Cell Carcinoma Treatment Market Value Share Analysis, by Treatment, 2016 and 2025
- Figure 35 : Asia Pacific Basal Cell Carcinoma Treatment Market Value Share Analysis, by End-user, 2016 and 2025
- Figure 36 : Asia Pacific Basal Cell Carcinoma Treatment Market Value Share Analysis, by Country, 2016 and 2025
- Figure 37 : Asia Pacific Basal Cell Carcinoma Treatment Market Attractiveness Analysis, by Treatment
- Figure 38 : Asia Pacific Basal Cell Carcinoma Treatment Market Attractiveness Analysis, by End-user
- Figure 39 : Latin America Basal Cell Carcinoma Treatment Market Size (US$ Mn) Forecast, 2015–2025
- Figure 40 : Latin America Basal Cell Carcinoma Treatment Market Attractiveness Analysis, by Country
- Figure 41 : Latin America Basal Cell Carcinoma Treatment Market Value Share Analysis, by Treatment, 2016 and 2025
- Figure 42 : Latin America Basal Cell Carcinoma Treatment Market Value Share Analysis, by End-user, 2016 and 2025
- Figure 43 : Latin America Basal Cell Carcinoma Treatment Market Value Share Analysis, by Country, 2016 and 2025
- Figure 44 : Latin America Basal Cell Carcinoma Treatment Market Attractiveness Analysis, by Treatment
- Figure 45 : Latin America Basal Cell Carcinoma Treatment Market Attractiveness Analysis, by End-user
- Figure 46 : Middle East & Africa Basal Cell Carcinoma Treatment Market Size (US$ Mn) Forecast, 2015–2025
- Figure 47 : Middle East & Africa Market Attractiveness Analysis, by Country
- Figure 48 : Middle East & Africa Market Value Share Analysis, by Treatment, 2016 and 2025
- Figure 49 : Middle East & Africa Market Value Share Analysis, by End-user, 2016 and 2025
- Figure 50 : Middle East & Africa Market Value Share Analysis, by Country, 2016 and 2025
- Figure 51 : Middle East & Africa Market Attractiveness Analysis, by Treatment
- Figure 52 : Middle East & Africa Market Attractiveness Analysis, by End-user
- Figure 53 : Global Basal Cell Carcinoma Market Share Analysis, by Company (2016)
- Figure 54 : Sun Pharmaceuticals Ltd Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2017
- Figure 55 : Sun Pharmaceuticals Ltd Breakdown of Net Sales, By Business Segments, 2017
- Figure 56 : Sun Pharmaceuticals Ltd Breakdown of Net Sales, by Region, 2017
- Figure 57 : Sun Pharmaceuticals Ltd R&D Expense (US$ Bn) & Y-o-Y Growth (%), 2015–2017
- Figure 58 : Valeant Pharmaceuticals International, Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2016
- Figure 59 : Valeant Pharmaceuticals International, Inc. Marketing and R&D Expenses, 2015–2016
- Figure 60 : Valeant Pharmaceuticals International, Inc. Breakdown of Net Sales, by Region, 2016
- Figure 61 : Valeant Pharmaceuticals International, Inc. Breakdown of Net Sales, by Business Segment, 2016
- Figure 62 : Mylan N.V. Marketing and R&D Expenses, 2015–2016
- Figure 63 : Mylan N.V. Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
- Figure 64 : Mylan N.V. Breakdown of Net Sales, by Region, 2016
- Figure 65 : F. Hoffmann-La Roche Ltd. Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2016
- Figure 66 : F. Hoffmann-La Roche Ltd. R&D Expenses, 2014–2016
- Figure 67 : F. Hoffmann-La Roche Ltd. Breakdown of Net Sales, by Region, 2016
- Figure 68 : Merck & Co., Inc. Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2016
- Figure 69 : Merck & Co., Inc. Breakdown of Net Sales, by Region, 2016
- Figure 70 : Merck & Co., Inc. Breakdown of Net Sales, by Business Segment, 2016
- Figure 71 : Merck & Co., Inc. R&D Expense (US$ Bn) & Y-o-Y Growth (%), 2014–2016
Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.